LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 136

Search options

  1. Article: Lower risk for COVID-19 hospitalization among patients in the United States with past vaccinations for herpes zoster and tetanus, diphtheria and pertussis.

    Salas, Joanne / Morley, John E / Hoft, Daniel F / Scherrer, Jeffrey F

    Preventive medicine reports

    2023  Volume 35, Page(s) 102302

    Abstract: Influenza, tetanus, diphtheria, and herpes zoster (HZ) vaccination received within 10 years of the COVID-19 pandemic have been associated with less severe COVID-19 infection. We expanded on this evidence to determine if a receiving two different ... ...

    Abstract Influenza, tetanus, diphtheria, and herpes zoster (HZ) vaccination received within 10 years of the COVID-19 pandemic have been associated with less severe COVID-19 infection. We expanded on this evidence to determine if a receiving two different vaccinations (i.e., HZ and tetanus, diphtheria, and pertussis (Tdap)) was associated with a lower risk for COVID-19 hospitalization. De-identified medical record data from a large mid-western health care system was used to determine if, compared to those with neither HZ or Tdap vaccination, patients with either HZ or Tdap and patients with both HZ and Tdap vaccination had lower risk for COVID-19 hospitalization between 4/1/2020 and 12/31/2020. Confounding was controlled using entropy balancing. Patients (n = 363,293) were 71.5 (±8.4) years of age, 57.8% female and 89.2% White race. Prior to controlling for confounding, as compared to patients without either vaccination, those that had either HZ or Tdap were significantly less likely to have a COVID-19 hospitalization (RR = 0.85; 95 %CI: 0.75-0.95). The risk for hospitalization decreased further among those with both HZ and Tdap vaccination (RR = 0.45; 95 %CI:0.28-0.71). After controlling for confounding, including healthy patient bias, receiving both vs. neither vaccinations remained significantly associated with a lower risk of COVID-19 hospitalization (RR = 0.48; 95 %CI: 0.26-0.90). Receiving both Tdap and HZ vaccination is associated with lower risk for COVID-19 hospitalization. Whether there is any benefit of past vaccination exposure in COVID-19 vaccinated patients should be investigated.
    Language English
    Publishing date 2023-06-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2785569-7
    ISSN 2211-3355
    ISSN 2211-3355
    DOI 10.1016/j.pmedr.2023.102302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Impact of BCG vaccination on the repertoire of human γδ T cell receptors.

    Xia, Mei / Blazevic, Azra / Fiore-Gartland, Andrew / Hoft, Daniel F

    Frontiers in immunology

    2023  Volume 14, Page(s) 1100490

    Abstract: Introduction: Tuberculosis (TB) caused by : Methods: In this study we performed γδ T cell receptor (TCR) repertoire sequencing of samples provided pre- and post-BCG vaccination from 10 individuals to identify specific receptors and TCR clones that ... ...

    Abstract Introduction: Tuberculosis (TB) caused by
    Methods: In this study we performed γδ T cell receptor (TCR) repertoire sequencing of samples provided pre- and post-BCG vaccination from 10 individuals to identify specific receptors and TCR clones that are induced by BCG.
    Results: Overall, there was no change in the diversity of γTCR or δTCR clonotypes in post- vs pre-BCG samples. Furthermore, the frequencies of TCR variable and joining region genes were minimally modulated by BCG vaccination at either the γTCR or δTCR loci. However, the γTCR and δTCR repertoires of individuals were highly dynamic; a median of ~1% of γTCR and ~6% of δTCR in the repertoire were found to significantly expand or contract in post- vs pre-BCG comparisons (FDR-q < 0.05). While many of the clonotypes whose frequency changed after BCG vaccination were not shared among multiple individuals in the cohort, several shared (i.e., "public") clonotypes were identified with a consistent increase or decrease in frequency across more than one individual; the degree of sharing of these clonotypes was significantly greater than the minimal sharing that would be expected among γTCR and δTCR repertoires. An
    Discussion: These findings generate hypotheses about specific γδTCR clonotypes that may expand in response to BCG vaccination and may recognize Mtb antigens. Future studies are required to validate and characterize these clonotypes, with an aim to better understand the role of γδ T cells in Mtb immunity.
    MeSH term(s) Adolescent ; Humans ; Receptors, Antigen, T-Cell, gamma-delta/genetics ; BCG Vaccine ; Tuberculosis/prevention & control ; Mycobacterium tuberculosis ; Vaccination
    Chemical Substances Receptors, Antigen, T-Cell, gamma-delta ; BCG Vaccine
    Language English
    Publishing date 2023-03-28
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1100490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tumor microenvironment metabolites directing T cell differentiation and function.

    Liu, Xia / Hoft, Daniel F / Peng, Guangyong

    Trends in immunology

    2021  Volume 43, Issue 2, Page(s) 132–147

    Abstract: Metabolic reprogramming of cancer cells creates a unique tumor microenvironment (TME) characterized by the limited availability of nutrients, which subsequently affects the metabolism, differentiation, and function of tumor-infiltrating T lymphocytes ( ... ...

    Abstract Metabolic reprogramming of cancer cells creates a unique tumor microenvironment (TME) characterized by the limited availability of nutrients, which subsequently affects the metabolism, differentiation, and function of tumor-infiltrating T lymphocytes (TILs). TILs can also be inhibited by tumor-derived metabolic waste products and low oxygen. Therefore, a thorough understanding of how such unique metabolites influence mammalian T cell differentiation and function can inform novel anticancer therapeutic approaches. Here, we highlight the importance of these metabolites in modulating various T cell subsets within the TME, dissecting how these changes might alter clinical outcomes. We explore potential TME metabolic determinants that might constitute candidate targets for cancer immunotherapies, ideally leading to future strategies for reprogramming tumor metabolism to potentiate anticancer T cell functions.
    MeSH term(s) Animals ; Cell Differentiation ; Humans ; Immunotherapy ; Lymphocytes, Tumor-Infiltrating/metabolism ; Mammals ; Neoplasms/metabolism ; Tumor Microenvironment
    Language English
    Publishing date 2021-12-29
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2036831-8
    ISSN 1471-4981 ; 1471-4906
    ISSN (online) 1471-4981
    ISSN 1471-4906
    DOI 10.1016/j.it.2021.12.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Development of vaccines to control the worldwide tuberculosis pandemic.

    Hoft, Daniel F

    Missouri medicine

    2014  Volume 111, Issue 4, Page(s) 326–331

    Abstract: Mycobacterium tuberculosis (Mtb) infection and tuberculosis (TB) disease are major public health problems. Available BCG vaccines are partially effective against severe disease, but have not reduced the overall prevalence of TB infection and disease. A ... ...

    Abstract Mycobacterium tuberculosis (Mtb) infection and tuberculosis (TB) disease are major public health problems. Available BCG vaccines are partially effective against severe disease, but have not reduced the overall prevalence of TB infection and disease. A third of the world's population is latently infected with Mtb, and therefore more effective prophylactic and therapeutic vaccines are urgently needed. The Hoft laboratory and the Saint Louis University Center for Vaccine Development (SLUCVD) are actively pursuing these important goals.
    MeSH term(s) Academic Medical Centers ; Adjuvants, Immunologic ; BCG Vaccine ; Drug Discovery/organization & administration ; Global Health ; Humans ; Missouri ; Mycobacterium tuberculosis/immunology ; Pandemics/prevention & control ; Research/organization & administration ; Tuberculosis/epidemiology ; Tuberculosis/immunology ; Tuberculosis/prevention & control
    Chemical Substances Adjuvants, Immunologic ; BCG Vaccine
    Language English
    Publishing date 2014-09-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 427362-x
    ISSN 0026-6620
    ISSN 0026-6620
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Research continues on new vaccines and biologics at the Saint Louis University Center for Vaccine Development.

    Hoft, Daniel F

    Missouri medicine

    2014  Volume 111, Issue 4, Page(s) 320

    MeSH term(s) Academic Medical Centers ; Biological Products ; Drug Discovery/organization & administration ; Humans ; Missouri ; Research/organization & administration ; Vaccines
    Chemical Substances Biological Products ; Vaccines
    Language English
    Publishing date 2014-09-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 427362-x
    ISSN 0026-6620
    ISSN 0026-6620
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.

    Liu, Xia / Hoft, Daniel F / Peng, Guangyong

    The Journal of clinical investigation

    2020  Volume 130, Issue 3, Page(s) 1073–1083

    Abstract: The functional state of the preexisting T cells in the tumor microenvironment is a key determinant for effective antitumor immunity and immunotherapy. Increasing evidence suggests that immunosenescence is an important state of T cell dysfunction that is ... ...

    Abstract The functional state of the preexisting T cells in the tumor microenvironment is a key determinant for effective antitumor immunity and immunotherapy. Increasing evidence suggests that immunosenescence is an important state of T cell dysfunction that is distinct from exhaustion, a key strategy used by malignant tumors to evade immune surveillance and sustain the suppressive tumor microenvironment. Here, we discuss the phenotypic and functional characteristics of senescent T cells and their role in human cancers. We also explore the possible mechanisms and signaling pathways responsible for induction of T cell senescence by malignant tumors, and then discuss potential strategies to prevent and/or reverse senescence in tumor-specific T cells. A better understanding of these critical issues should provide novel strategies to enhance cancer immunotherapy.
    MeSH term(s) Animals ; Cellular Senescence/immunology ; Humans ; Immunotherapy ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/therapy ; Signal Transduction/immunology ; Tumor Microenvironment/immunology
    Language English
    Publishing date 2020-02-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI133679
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Influenza Challenge Models: Ready for Prime Time?

    Bernstein, David I / Atmar, Robert L / Hoft, Daniel F

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 71, Issue 11, Page(s) 3012–3013

    MeSH term(s) Healthy Volunteers ; Humans ; Influenza A Virus, H3N2 Subtype ; Influenza A virus ; Influenza, Human/epidemiology ; Orthomyxoviridae Infections
    Language English
    Publishing date 2020-03-23
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciaa278
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.

    Wiemken, Timothy L / Salas, Joanne / Hoft, Daniel F / Jacobs, Christine / Morley, John E / Scherrer, Jeffrey F

    Vaccine

    2022  Volume 40, Issue 26, Page(s) 3529

    MeSH term(s) Cohort Studies ; Dementia/epidemiology ; Dementia/prevention & control ; Humans ; Influenza, Human/prevention & control ; Vaccination/adverse effects ; Veterans
    Language English
    Publishing date 2022-05-26
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2022.04.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques.

    Hoft, Stella G / Kauffman, Keith D / Sakai, Shunsuke / Lindestam Arlehamn, Cecilia S / Sette, Alessandro / Hoft, Daniel F / Herbert, Richard / Barber, Daniel L

    mBio

    2023  Volume 14, Issue 2, Page(s) e0022023

    Abstract: Alternative delivery routes of the current Mycobacterium tuberculosis (Mtb) vaccine, intradermally (ID) delivered BCG, may provide better protection against tuberculosis, and be more easily administered. Here, we use rhesus macaques to compare the airway ...

    Abstract Alternative delivery routes of the current Mycobacterium tuberculosis (Mtb) vaccine, intradermally (ID) delivered BCG, may provide better protection against tuberculosis, and be more easily administered. Here, we use rhesus macaques to compare the airway immunogenicity of BCG delivered via either ID or intragastric gavage vaccination. Ag-specific CD4 T cell responses in the blood were similar after BCG vaccination via gavage or ID injection. However, gavage BCG vaccination induced significantly lower T cell responses in the airways compared to intradermal BCG vaccination. Examining T cell responses in lymph node biopsies showed that ID vaccination induced T cell priming in skin-draining lymph nodes, while gavage vaccination induced priming in the gut-draining nodes, as expected. While both delivery routes induced highly functional Ag-specific CD4 T cells with a Th1* phenotype (CXCR3
    MeSH term(s) Animals ; Humans ; BCG Vaccine ; Macaca mulatta ; Lung/microbiology ; Tuberculosis/prevention & control ; Th1 Cells ; Mycobacterium tuberculosis ; Mycobacterium bovis/genetics ; CD4-Positive T-Lymphocytes ; Vaccination
    Chemical Substances BCG Vaccine
    Language English
    Publishing date 2023-03-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mbio.00220-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Immunotherapy for tuberculosis: future prospects.

    Abate, Getahun / Hoft, Daniel F

    ImmunoTargets and therapy

    2016  Volume 5, Page(s) 37–45

    Abstract: Tuberculosis (TB) is still a major global health problem. A third of the world's population is infected with Mycobacterium tuberculosis. Only ~10% of infected individuals develop TB but there are 9 million TB cases with 1.5 million deaths annually. The ... ...

    Abstract Tuberculosis (TB) is still a major global health problem. A third of the world's population is infected with Mycobacterium tuberculosis. Only ~10% of infected individuals develop TB but there are 9 million TB cases with 1.5 million deaths annually. The standard prophylactic treatment regimens for latent TB infection take 3-9 months, and new cases of TB require at least 6 months of treatment with multiple drugs. The management of latent TB infection and TB has become more challenging because of the spread of multidrug-resistant and extremely drug-resistant TB. Intensified efforts to find new TB drugs and immunotherapies are needed. Immunotherapies could modulate the immune system in patients with latent TB infection or active disease, enabling better control of M. tuberculosis replication. This review describes several types of potential immunotherapies with a focus on those which have been tested in humans.
    Language English
    Publishing date 2016-04-20
    Publishing country New Zealand
    Document type Journal Article ; Review
    ISSN 2253-1556
    ISSN 2253-1556
    DOI 10.2147/ITT.S81892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top